Table 2.
Patient characteristics (n = 192)
| Characteristics | Number (%) or Median (range) or Mean (±SD) |
|---|---|
| Female | 116 (60.4) |
| Age (years) | 48.3 ± 13.0 |
| Age at diagnosis, years | 33.5 (11-64) |
| Disease duration, years | 11 (0-53) |
| APS 2, n (%) | 109 (56.8) |
| Use of hydrocortisone, n (%) | 74 (38.5) |
| Use of cortisone acetate, n (%) | 118 (61.5) |
| Hydrocortisone equivalent doses, mg/day | 20 (7.5-50.0) |
| Use of fludrocortisone, n (%) | 189 (98.4) |
| Total fludrocortisone dose, mg/day | 0.10 (0.03-0.30) |
| Women using DHEA, n (%) | 16 (13.8) |
| Body mass index, kg/cm2 | 24.4 (16.6-38.3) |
| Systolic blood pressure, mmHg | 120 (84-169) |
| Diastolic blood pressure, mmHg | 76 (50-95) |
| Hyperpigmentation, n (%) | 100 (52.4) |
Abbreviations: APS, autoimmune polyendocrine syndrome; DHEA, dehydroepiandrosterone; SD, standard deviation.